ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

NCAB Committee Close To Definition Of QRA

February 11, 1983